DAS28 remission and clinical efficacy in rheumatoid arthritis patients with inadequate responses to methotrexate treated with abatacept: The Phase III AIM trial and a Phase IIB trial long-term extension

被引：0
|
作者：
Westhovens, R
Kremer, J
Shergy, W
Abud-Mendoza, C
Aranda, R
Becker, JC
Zhou, Y
Mokliatchouk, O
Dougados, M
机构：
[1] Univ Hosp Gasthuisberg, Louvain, Belgium
[2] Ctr Rheumatol, Albany, NY USA
[3] Albany Med Coll, Albany, NY 12208 USA
[4] Rheumatol Assoc N Alabama, Huntsville, AL USA
[5] Hosp Cent Ignac Morones Prieto, San Luis Potosi, Mexico
[6] Bristol Myers Squibb Co, Princeton, NJ USA
[7] Hosp Cochin, Paris, France
来源：
ARTHRITIS AND RHEUMATISM | 2005年 / 52卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S142 / S142
页数：1
相关论文
共 50 条
  • [41] An open-label, long-term, phase III extension trial of duloxetine in Japanese patients with fibromyalgia
    Murakami, Masato
    Osada, Kenichi
    Ichibayashi, Hisao
    Mizuno, Hiromichi
    Ochiai, Toshimitsu
    Ishida, Mitsuhiro
    Alev, Levent
    Nishioka, Kusuki
    MODERN RHEUMATOLOGY, 2017, 27 (04) : 688 - 695
  • [42] Long-term remission, efficacy and safety in patients with rheumatoid arthritis treated with adalimumab (Humira®) plus methotrexate for more than 5 years
    Breedveld, FC
    Rau, R
    Van Riel, P
    van de Putte, L
    Schattenkirchner, M
    Kupper, H
    Segurado, O
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 268 - 268
  • [43] Efficacy and safety of the selective co-stimulation modulator abatacept with methotrexate for treating rheumatoid arthritis: 1-year clinical and radiographic results from the phase III AIM
    Russell, A
    Kremer, J
    Westhovens, R
    Moreland, L
    Emery, P
    Ge, ZY
    Aranda, R
    Becker, JC
    JOURNAL OF RHEUMATOLOGY, 2005, 32 (07) : 1394 - 1394
  • [44] Long-Term Efficacy for Parkinsonism and Safety of Zonisamide in Patients with Dementia with Lewy Bodies: A Phase III Trial
    Toya, Shunji
    Murata, Miho
    Odawara, Toshinari
    Hasegawa, Kazuko
    Kajiwara, Ritsuko
    Takeuchi, Hisao
    Takai, Kentaro
    Kosaka, Kenji
    NEUROLOGY, 2019, 92 (15)
  • [45] Upadacitinib Versus Placebo or Adalimumab in Patients With Rheumatoid Arthritis and an Inadequate Response to Methotrexate: Results of a Phase III, Double-Blind, Randomized Controlled Trial
    Fleischmann, Roy
    Pangan, Aileen L.
    Song, In-Ho
    Mysler, Eduardo
    Bessette, Louis
    Peterfy, Charles
    Durez, Patrick
    Ostor, AndrewJ
    Li, Yihan
    Zhou, Yijie
    Othman, Ahmed A.
    Genovese, Mark C.
    ARTHRITIS & RHEUMATOLOGY, 2019, 71 (11) : 1788 - 1800
  • [46] FATIGUE IS AN INDEPENDENT VARIABLE PREDICTING PHYSICAL FUNCTION AND DAS-28 REMISSION FOR PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH INTRAVENOUSLY ADMINISTERED GOLIMUMAB: RESULTS FROM A PHASE 3, PLACEBO CONTROLLED CLINICAL TRIAL
    Westhovens, R.
    Weinblatt, M. E.
    Han, C.
    Gathany, T.
    Kim, L.
    Mack, M.
    Lu, J.
    Baker, D.
    Mendelsohn, A.
    Bingham, C.
    VALUE IN HEALTH, 2012, 15 (04) : A42 - A42
  • [47] Abatacept provides significant and clinically meaningful efficacy in rheumatoid arthritis patients with inadequate responses to anti-TNF therapy: Disease activity score 28 assessments in the attain trial
    Dougados, M
    Sherrer, Y
    Russell, A
    Carrabba, M
    Nuamah, I
    Becker, J
    Aranda, R
    Luggen, M
    ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 : 458 - 458
  • [48] Sustained efficacy along with improvements in disease activity score 28 (DAS 28) and patient (Pt)-reported outcomes (PROs) with abatacept (Aba) in rheumatoid arthritis (RA) pts with an inadequate response to anti-tumor necrosis factor (TNF) therapy: The long-term extension (LTE) of the attain trial
    Dougados, M.
    Schiff, M.
    Luggen, M.
    Becker, J. C.
    Aranda, R.
    Li, T.
    McCann, T.
    Schmidely, N.
    LeBars, M.
    Sibilia, J.
    Genovese, M. C.
    RHEUMATOLOGY, 2007, 46 : I99 - I99
  • [49] Long-term abatacept treatment for 48 weeks in patients with primary Sjogren's syndrome: The open-label extension phase of the ASAP-III trial
    de Wolff, Liseth
    van Nimwegen, Jolien F.
    Mossel, Esther
    van Zuiden, Greetje S.
    Stel, Alja J.
    Majoor, Kalle, I
    Olie, Lisette
    Los, Leonoor, I
    Vissink, Arjan
    Spijkervet, Fred K. L.
    Verstappen, Gwenny M. P. J.
    Kroese, Frans G. M.
    Arends, Suzanne
    Bootsma, Hendrika
    SEMINARS IN ARTHRITIS AND RHEUMATISM, 2022, 53
  • [50] Analysis of Infections and All-Cause Mortality in Phase II, Phase III, and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis
    Cohen, Stanley
    Radominski, Sebastiao C.
    Gomez-Reino, Juan J.
    Wang, Lisy
    Krishnaswami, Sriram
    Wood, Susan P.
    Soma, Koshika
    Nduaka, Chudi I.
    Kwok, Kenneth
    Valdez, Hernan
    Benda, Birgitta
    Riese, Richard
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 (11) : 2924 - 2937
12345